Laurent Eckert
8PUBLICATIONS
25CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (8)
Sort by Publication Date:
|Jan 04, 2021
Recommended core outcome instruments for health-related quality of life, long-term control and itch intensity in atopic eczema trials: results of the HOME VII consensus meeting.K S Thomas, C A Apfelbacher, J R Chalmers
|Nov 12, 2020
Recommended core outcome instruments for health-related quality of life, long-term control and itch intensity in atopic eczema trials: results of the HOME VII consensus meeting.K S Thomas, C A Apfelbacher, J R Chalmers
|Sep 07, 2020
A phase 2, open-label study of single-dose dupilumab in children aged 6 months to <6 years with severe uncontrolled atopic dermatitis: pharmacokinetics, safety and efficacy.A S Paller, E C Siegfried, E L Simpson
|Aug 14, 2020
Dupilumab significantly improves sleep outcomes in adult patients with atopic dermatitis: results from five randomized clinical trials.L A Beck, J I Silverberg, E L Simpson
|Oct 10, 2019
Dupilumab in adolescents with uncontrolled moderate-to-severe atopic dermatitis: results from a phase IIa open-label trial and subsequent phase III open-label extension.M J Cork, D Thaçi, L F Eichenfield
|Oct 07, 2019
The patient-reported disease burden in adults with atopic dermatitis: a cross-sectional study in Europe and Canada.M de Bruin-Weller, A Gadkari, S Auziere
Pageof 2
Frequent Collaborators
2 joint publications
J I Silverberg
2 joint publications
E Grinich
2 joint publications
B L Stuart
2 joint publications
T Pawlitschek
2 joint publications
J Schmitt
2 joint publications
A Bansal
2 joint publications
L A A Gerbens
2 joint publications
J R Chalmers
2 joint publications
K S Thomas
2 joint publications
C A Apfelbacher
